Illuccix Kit
Product Images NDC 74725-100

8 FDA label images from Telix Pharmaceuticals (us) Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Illuccix (NDC 74725-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Telix Pharmaceuticals (us) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Illuccix 01)

Figure 1 (Illuccix 01)
A flowchart showing the preparation process of ILLUCCIX gallium Ga 68 gozetotide injection. It outlines combining Gozetotide vial 1 with acetate buffer vial 2A, then transferring this solution to sterile vacuumed reaction vial 3 with gallium Ga 68 chloride solution, resulting in gallium Ga 68 gozetotide injection. The final step is quality control testing for radiochemical purity, pH, and appearance.*
FDA Label Image

Figure 2 (Illuccix 02)

Figure 2 (Illuccix 02)
A process flow diagram illustrating the preparation steps for ILLUCCIX Gallium Ga 68 gozetotide injection. The diagram shows the elution of 5 mL sterile ultrapure HCl into an EZAG Gallia Pharm Generator to produce Gallium Ga 68 Chloride solution, which is collected in Vial 3. The solution is then combined with acetate buffer (Vial 2A) and gozetotide (Vial 1), followed by mixing and transfer steps to produce the final Gallium Ga 68 Gozetotide injection (Vial 3, 7.5 mL). The final step includes quality control testing for radiochemical purity, pH, and appearance.*
FDA Label Image

Figure 3 (Illuccix 03)

Figure 3 (Illuccix 03)
Flowchart illustrating the preparation of gallium Ga 68 gozetotide injection using the ILLUCCIX kit. It details the process starting from the ARTMS QIS solid target system to collecting gallium Ga 68 chloride solution, mixing with acetate buffer and gozetotide, transferring to a sterile vacuumed reaction vial, and performing quality control for purity, pH, and appearance.*
FDA Label Image

Figure 4 (Illuccix 04)

Figure 4 (Illuccix 04)
Packaging label for ILLUCCIX kit for the preparation of gallium Ga 68 gozetotide injection, 25 mcg/vial gozetotide by Telix Pharmaceuticals (US) Inc. The label is primarily navy blue and white with design elements including the product name, dosage strength, route as intravenous use, and usage instructions. The label includes information about the contents of the kit, the lot and expiry print area, and storage instructions.*
FDA Label Image

Figure 5 (Illuccix 05)

Figure 5 (Illuccix 05)
Box packaging label for ILLUCCIX kit for the preparation of gallium Ga 68 gozetotide injection, 25 mcg/vial gozetotide by Telix Pharmaceuticals (US) Inc. The label includes storage instructions, usage information for intravenous use only, and contents of the multi-dose kit. It features a blue and white color scheme with the Telix Pharmaceuticals logo and mentions configuration B for use with IRE Galli Eo.*
FDA Label Image

Figure 6 (Illuccix 06)

Figure 6 (Illuccix 06)
Chemical structure diagram showing the molecular arrangement of gallium Ga 68 gozetotide, the active ingredient in ILLUCCIX, a kit for intravenous injection used in human prescription drugs.*
FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
Packaging label for ILLUCCIX kit for the preparation of gallium Ga 68 gozetotide injection, 25 mcg per vial. This multi-dose kit is for intravenous use and labeled by Telix Pharmaceuticals (US) Inc. The label provides product information, storage instructions, handling warnings, and manufacturer location in Grand Rapids, MI, USA.*
FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
Packaging label for ILLUCCIX kit for the preparation of gallium Ga 68 gozetotide injection, 25 mcg/vial gozetotide. This human prescription drug kit is for intravenous use only and is supplied by Telix Pharmaceuticals (US) Inc. The label describes Configuration B for use with specific solid targets and includes storage instructions, warning for healthcare professionals, and manufacturer details. The design features a gradient blue and green background with branding on multiple sides.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.